Inventor · disambiguated record
Hans Lentzen
Also filed as: LENTZEN HANS
6 granted patents·5 pending applications·35 citations·filing 1995–2021
78Inventor score
Top patents by PatentIndex Score
11 records- 0178US9981007B2Drug containing recombinant mistletoe lectins for treating malignant melanomaCYTAVIS BIOPHARMA GMBH·Filed 2016·Granted May 29, 2018·3 cites·10 claims
- 0268US9839669B2Antiviral agent comprising recombinant mistletoe lectinsCYTAVIS BIOPHARMA GMBH·Filed 2016·Granted Dec 12, 2017·1 cites·8 claims
- 0365US2021379143A1Drug containing recombinant mistletoe lectins for treatingMELEMA PHARMA GMBH·Filed 2021·Application pending·0 cites
- 0456US6271368B1Recombinant mistletoe lectin (rML)MADAUS AG KOELN·Filed 1996·Granted Aug 7, 2001·22 cites·56 claims
- 0554US2018243366A1Drug containing recombinant mistletoe lectins for treating malignant melanomaCYTAVIS BIOPHARMA GMBH·Filed 2018·Application pending·0 cites
- 0652US10413586B2Antiviral agent comprising recombinant mistletoe lectinsMELEMA PHARMA GMBH·Filed 2017·Granted Sep 17, 2019·0 cites·10 claims
- 0751US2014080764A1Drug Containing Recombinant Mistletoe Lectins for Treating Malignant MelanomaLENTZEN HANS·Filed 2012·Application pending·0 cites
- 0849US10722553B2Medicament containing recombinant mistletoe lectins for the treatment of brain tumorsMELEMA PHARMA GMBH·Filed 2017·Granted Jul 28, 2020·0 cites·11 claims
- 0948US2014128317A1Antiviral agent comprising recombinant mistletoe lectinsLENTZEN HANS·Filed 2012·Application pending·0 cites
- 1044US2014220076A1Recombinant Mistletoe Lectin and use Thereof as an AdjuvantWITTHOHN KLAUS·Filed 2012·Application pending·0 cites
- 1143US5714473AUse of flavolignans as adjuvants in tumour therapyMADAUS AG·Filed 1995·Granted Feb 3, 1998·9 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Hans Lentzen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →